CHARMD

Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database


  • TOP

    C592G

    Antiviral assays:

    Antiviral EC50 ratio Phenotype Strain Source Marker Assay Reference
    Filociclovir 2.20-4.90 Range of values between Low level resistance and Intermediate level resistance Laboratory strain, Clinical Isolate Recombinant Details Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance. (Apr 2020)
    Maribavir 0.78 No resistance Laboratory strain, Clinical Isolate Recombinant Details Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants. (Feb 2024)
    Ganciclovir 3.20 Intermediate level resistance Laboratory strain, Clinical Isolate Recombinant Details Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants. (Feb 2024)
    Ganciclovir 3.00 Intermediate level resistance Clinical Isolate Details Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene. (Feb 2017)
    Ganciclovir 3.10 Intermediate level resistance Clinical Isolate Details Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene. (Feb 2017)
    Ganciclovir 3.10 Intermediate level resistance Clinical Isolate Details Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. (Sep 2022)

    Mutations at the same locus:

    Mutant Resistances
    C592F Ganciclovir: High level resistance


    Tilloy et al., 2024
    Interdeposit Digital Number: IDDN.FR.001.420004.000.S.X.2024.000.31230